Published in Ann Intern Med on February 15, 1997
Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J Clin Invest (2013) 1.53
Glycogen synthase kinase-3β inhibition ameliorates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice. Diabetes (2014) 1.45
Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin (2012) 1.19
Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm (2011) 1.12
Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age. Eur J Heart Fail (2010) 0.99
Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J (2009) 0.95
Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One (2012) 0.93
Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Rev (2008) 0.93
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord (2010) 0.90
Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J Card Fail (2007) 0.89
Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry. Korean J Intern Med (2012) 0.89
Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health (2002) 0.85
Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis. Cardiovasc Diabetol (2011) 0.81
Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors. World J Cardiol (2014) 0.81
Glutamine Modulates Macrophage Lipotoxicity. Nutrients (2016) 0.81
Stem cells in the diabetic infarcted heart. Heart Fail Rev (2010) 0.80
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. BMC Cardiovasc Disord (2007) 0.79
Mortality after myocardial infarction in patients with diabetes mellitus. Heart (2007) 0.77
Stem cells and diabetic cardiomyopathy: from pathology to therapy. Heart Fail Rev (2016) 0.77
Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy. Cardiovasc Diabetol (2016) 0.77
Hyperglycemia-Induced Hypovolemia Is Involved in Early Cardiac Magnetic Resonance Alterations in Streptozotocin-Induced Diabetic Mice: A Comparison with Furosemide-Induced Hypovolemia. PLoS One (2016) 0.76
Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications. HIV Clin Trials (2013) 0.76
Atypical presentation of acute and chronic coronary artery disease in diabetics. World J Cardiol (2014) 0.76
Coronary artery disease and diabetes mellitus. Cardiol Clin (2014) 0.76
Significance of inflammatory markers in diabetic patients with stable coronary artery disease. Korean J Intern Med (2009) 0.75
Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction. Res Cardiovasc Med (2015) 0.75
Sex differences in epidemiology and risk factors of acute coronary syndrome in Chinese patients with type 2 diabetes: a long-term prospective cohort study. PLoS One (2015) 0.75
Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension. Biomed Res Int (2016) 0.75
Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes. Am J Transl Res (2016) 0.75
Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning. J Cell Physiol (2016) 0.75
Non-linear actions of physiological agents: Finite disarrangements elicit fitness benefits. Redox Biol (2017) 0.75
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Cardiovascular disease in women. Circulation (1993) 1.87
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation (1990) 1.57
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet (1994) 1.55
Diabetes mellitus and male sexual function: a controlled study. Diabetologia (1993) 1.53
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Refractory prinzmetal angina treated with cyproheptadine. Ann Intern Med (1994) 1.48
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. Circulation (2000) 1.45
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45
Shape and mechanics in thalattosuchian (Crocodylomorpha) skulls: implications for feeding behaviour and niche partitioning. J Anat (2009) 1.43
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Finite element modelling of squirrel, guinea pig and rat skulls: using geometric morphometrics to assess sensitivity. J Anat (2011) 1.36
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med (2001) 1.24
Complete occlusion of the left main coronary artery and the importance of coronary collateral circulation. Mayo Clin Proc (1977) 1.22
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation (1986) 1.21
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol (1995) 1.18
Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol (1996) 1.15
Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis (1986) 1.15
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation (1994) 1.12
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation (1989) 1.11
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08
Coronary atherosclerosis. A multifactorial disease. Circulation (1993) 1.08
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis (2000) 1.08
Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation (1987) 1.07
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol (1985) 1.07
Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1985) 1.05
Patterns of foot examination in a diabetes clinic. Am J Med (1985) 1.05
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation (1986) 1.05
Plaque rupture, thrombosis, and therapeutic implications. Haemostasis (1996) 1.04
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol (1995) 1.03
Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors. Circulation (1979) 1.02
Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease. N Engl J Med (1998) 1.01
Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug. Circulation (1988) 0.98
Impaired carbohydrate metabolism during a mild viral illness. N Engl J Med (1973) 0.97
The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol (1991) 0.95
Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum (1984) 0.94
Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Arch Intern Med (1999) 0.94
Retracted What makes an accurate and reliable subject-specific finite element model? A case study of an elephant femur. J R Soc Interface (2011) 0.94
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation (1990) 0.93
Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation (1999) 0.93
Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. J Biomed Mater Res (1997) 0.93
Mechanisms of unstable angina. N Engl J Med (1986) 0.93
Effects of acute endotoxemia on glucoregulation in normal and diabetic subjects. J Clin Endocrinol Metab (1977) 0.92
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation (1987) 0.92
Disopyramide (Norpace)-induced hypoglycemia. Am J Med (1980) 0.92
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. J Am Coll Cardiol (1991) 0.92
Small cell tumors of the thyroid. A clinicopathologic study. Cancer (1971) 0.92
Platelet inhibitor agents in cardiovascular disease: an update. J Am Coll Cardiol (1989) 0.91
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J (1986) 0.90
Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation (1998) 0.90
Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Thromb Haemost (1994) 0.89
The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost (1995) 0.89
Intracellular calcium transients in human working myocardium as detected with aequorin. J Am Coll Cardiol (1984) 0.89
Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity. Diabetes (1981) 0.89
Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. Circulation (1989) 0.88
Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation (1993) 0.88
Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. Circulation (1994) 0.88
Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries. Circulation (1998) 0.88
Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol (1986) 0.87
Virtual experiments, physical validation: dental morphology at the intersection of experiment and theory. J R Soc Interface (2012) 0.87
C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Diabetologia (1980) 0.87
Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol (2000) 0.87
Virus-induced pancreatic disease by Venezuelan encephalitis virus. Alterations in glucose tolerance and insulin release. Diabetes (1976) 0.87
Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesia. J Am Coll Cardiol (1990) 0.87
Infection-induced hyperglucagonemia and altered hepatic response to glucagon in the rat. Am J Physiol (1974) 0.87
Rubella virus-induced diabetes in the hamster. Diabetes (1986) 0.86
A new approach for local intravascular drug delivery. Iontophoretic balloon. Circulation (1994) 0.86
Thrombosis in unstable angina. N Engl J Med (1992) 0.86
Relationship between serum chromium concentrations and glucose utilization in normal and infected subjects. Diabetes (1975) 0.86
Platelet-inhibitor drugs' role in coronary artery disease. Prog Cardiovasc Dis (1987) 0.86
Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol (1985) 0.86
Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration. Am J Physiol (1975) 0.85
Dynamic thrombosis and thrombolysis. Role of antithrombins. Circulation (1991) 0.85
Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis (1998) 0.84
Atherothrombosis: mechanisms and clinical therapeutic approaches. Vasc Med (1998) 0.84
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. Circulation (1996) 0.84
Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation (1994) 0.84
Effects of acute endotoxemia and glucose administration on circulating leukocyte populations in normal and diabetic subjects. Metabolism (1978) 0.84
Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J Am Coll Cardiol (1986) 0.83
Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin. Arterioscler Thromb Vasc Biol (2000) 0.83
Red and blonde hair in renal medullary cystic disease. Arch Intern Med (1972) 0.83
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial. J Am Coll Cardiol (1985) 0.83
Viruses and the pathogenesis of diabetes mellitus. Diabetes (1978) 0.83